BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28118799)

  • 1. Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications.
    Hashemi ZS; Khalili S; Forouzandeh Moghadam M; Sadroddiny E
    Expert Rev Respir Med; 2017 Feb; 11(2):147-157. PubMed ID: 28118799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.
    Zarredar H; Ansarin K; Baradaran B; Shekari N; Eyvazi S; Safari F; Farajnia S
    Anticancer Agents Med Chem; 2018; 18(14):1991-2005. PubMed ID: 30088452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in human lung cancer.
    Kang SM; Lee HJ
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1505-13. PubMed ID: 24872439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs in lung cancer: a link to aging.
    Zagryazhskaya A; Zhivotovsky B
    Ageing Res Rev; 2014 Sep; 17():54-67. PubMed ID: 24631464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNAs in diagnosis and prognosis in lung cancer].
    Avila-Moreno F; Urrea F; Ortiz-Quintero B
    Rev Invest Clin; 2011; 63(5):516-35. PubMed ID: 22468482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test performance of sputum microRNAs for lung cancer: a meta-analysis.
    Liao QB; Guo JQ; Zheng XY; Zhou ZF; Li H; Lai XY; Ye JF
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):562-7. PubMed ID: 24892736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of extracellular vesicle microRNAs in cancer biology.
    Takahashi RU; Prieto-Vila M; Hironaka A; Ochiya T
    Clin Chem Lab Med; 2017 May; 55(5):648-656. PubMed ID: 28231055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-associated carcinogenesis in lung carcinoma.
    Pratap P; Raza ST; Abbas S; Mahdi F
    J Cancer Res Ther; 2018; 14(2):249-254. PubMed ID: 29516903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
    Zhang WC; Chin TM; Yang H; Nga ME; Lunny DP; Lim EK; Sun LL; Pang YH; Leow YN; Malusay SR; Lim PX; Lee JZ; Tan BJ; Shyh-Chang N; Lim EH; Lim WT; Tan DS; Tan EH; Tai BC; Soo RA; Tam WL; Lim B
    Nat Commun; 2016 Jun; 7():11702. PubMed ID: 27325363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-183 regulates Ezrin expression in lung cancer cells.
    Wang G; Mao W; Zheng S
    FEBS Lett; 2008 Oct; 582(25-26):3663-8. PubMed ID: 18840437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
    Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
    Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.